Cyclic phosphinate derivatives and method of preparing the same

US9487547B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9487547-B2
Application numberUS-201514598143-A
CountryUS
Kind codeB2
Filing dateJan 15, 2015
Priority dateMay 2, 2014
Publication dateNov 8, 2016
Grant dateNov 8, 2016

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Provided are novel cyclic phosphinate derivatives and a method of preparing the same, and more particularly, cyclic phosphinate derivatives including benzoxaphosphole oxide derivatives and benzoxaphosphorin oxide derivatives, and a method of preparing the same. The cyclic phosphinate derivative according to the present invention may have pharmacological and physiological activities, be used as the basic skeleton of the natural material, and be used in development of a new drug, and synthesis of various medicines. In addition, with the method of preparing a cyclic phosphinate derivative according to the present invention, various cyclic phosphinate derivatives may be prepared with high yield through a simple synthetic process by performing an intramolecular carbon-oxygen coupling reaction on the phosphinic acid derivative in the presence of a palladium (Pd) catalyst, an oxidant, and a base.

First claim

Opening claim text (preview).

What is claimed is: 1. A cyclic phosphinate compound represented by the following Chemical Formula 1: in Chemical Formula 1, R 1 is (C1-C20)alkyl; R 2 to R 4 are each independently hydrogen, (C1-C20)alkyl, halo(C1-C20)alkyl, (C1-C20)alkoxy, (C6-C20)aryl, halogen, (C6-C20)aryloxy, or tri(C1-C20)alkylsilyl; when X is  Y is O; R 5 is (C1-C20)alkyl, (C1-C20)alkoxy, or (C6-C20)aryl; Z is —CR 11 R 12 —; R 11 and R 12 are each independently hydrogen or (C1-C20)alkyl, or are linked to each other by (C1-C7)alkylene to form a spiro ring; and the alkyl and aryl of R 2 to R 5 are optionally substituted with a substituent selected from the group consisting of halogen, (C1-C20)alkyl, (C1-C20)alkoxy, and halo(C1-C20)alkyl. 2. The cyclic phosphinate compound of claim 1 , wherein it is represented by the following Chemical Formula 2: in Chemical Formula 2, R 1 to R 4 and R 5 have the same definitions as defined in claim 1 ; Z is —CH2—; and the alkyl and aryl of R 2 to R 5 are optionally substituted with a substituent selected from the group consisting of halogen, (C1-C20)alkyl, (C1-C20)alkoxy, and halo(C1-C20)alkyl. 3. The cyclic phosphinate compound of claim 2 , wherein R 1 is methyl, ethyl, propyl, butyl, pentyl, or hexyl; R 2 to R 4 are each independently hydrogen, methyl, ethyl, propyl, butyl, pentyl, hexyl, trifluoromethyl, methoxy, ethoxy, propoxy, butoxy, pentyloxy, hexyloxy, phenyl, naphthyl, fluorenyl, chloro, bromo, fluoro, or trimethylsilyl (TMS), the phenyl, naphthyl, or fluorenyl of R 2 to R 4 are optionally substituted with a substituent selected from the group consisting of chloro, bromo, fluoro, methyl, ethyl, propyl, butyl, pentyl, hexyl, methoxy, ethoxy, propoxy, butoxy, pentyloxy, hexyloxy, and trifluoromethyl; R 5 is methyl, ethyl, propyl, butyl, pentyl, hexyl, methoxy, ethoxy, propoxy, butoxy, pentyloxy, hexyloxy, phenyl, or naphthyl, the phenyl or naphthyl of R 5 are optionally substituted with a substituent selected from the group consisting of chloro, bromo, fluoro, methyl, ethyl, propyl, butyl, pentyl, hexyl, methoxy, ethoxy, propoxy, butoxy, pentyloxy, hexyloxy, and trifluoromethyl; and Z is —CH 2 —. 4. The cyclic phosphinate compound of claim 3 , wherein it is selected from the following compounds: 5. A method of preparing a cyclic phosphinate compound characterized by performing an intramolecular carbon-oxygen coupling reaction on a phosphinic acid compound represented by the following Chemical Formula 6 to prepare a cyclic phosphinate compound represented by the following Chemical Formula 2 in the presence of a palladium (Pd) catalyst, an oxidant, and a base: in Chemical Formulas 2 and 6, R 1 is (C1-C20)alkyl; R 2 to R 4 are each independently hydrogen, (C1-C20)alkyl, halo(C1-C20)alkyl, (C1-C20)alkoxy, (C6-C20)aryl, halogen, (C6-C20)aryloxy, or tri(C1-C20)alkylsilyl; R 5 is (C1-C20)alkyl, (C1-C20)alkoxy, or (C6-C20)aryl; Z is —CH 2 —; and the alkyl and aryl of R 2 to R 5 are optionally substituted with a substituent selected from the group consisting of halogen, (C1-C20)alkyl, (C1-C20)alkoxy, and halo(C1-C20)alkyl. 6. The method of preparing a cyclic phosphinate compound of claim 5 , wherein the palladium (Pd) catalyst is one or two or more selected from the group consisting of PdCl 2 , PdBr 2 , Pd(OAc) 2 , Pd(dba) 2 , Pd 2 (dba) 3 , Pd 2 dba 3 .CHCl 3 , Pd(PPh 3 ) 4 , Pd(OTf) 2 , Pd(OTf) 2 .2H 2 O, Pd(TFA) 2 , PdCl 2 (MeCN) 2 , PdCl 2 (PPh 3 ) 2 , Pd(dppf)Cl 2 , and [PdCl(C 3 H 5 )] 2 . 7. The method of preparing a cyclic phosphinate compound of claim 5 , wherein a use amount of the palladium (Pd) catalyst is 0.01 to 0.5 equivalents with respect to the phosphinic acid compound represented by Chemical Formula 6. 8. The method of preparing a cyclic phosphinate compound of claim 5 , wherein the oxidant is one or two or more selected from the group consisting of CuCl, Cu 2 O, CuO, Cu(OAc) 2 , Cu(OTf) 2 [OTf: trifluoromethanesulfonate], CuCl 2 , CuBr, CuI, Cu(acac) 2 , Ag 2 O, AgO, AgOAc, Ag 2 CO 3 , Na 2 S 2 O 8 , K 2 S 2 O 8 , NaOAc, BQ [BQ: benzoquinone], FeCl 3 , Mn(OAc) 3 .2H 2 O, V 2 O 5 , PhI(OAc) 2 , PhI(TFA) 2 , IOAc, ozone, oxygen, (PhCO 2 ) 2 , and 2,2,6,6-tetramethyl-1-piperidinyloxy (free radical, TEMPO). 9. The method of preparing a cyclic phosphinate compound of claim 5 , wherein a use amount of the oxidant is 0.1 to 5.0 equivalents with respect to the phosphinic acid compound represented by Chemical Formula 6. 10. The method of preparing a cyclic phosphinate compound of claim 5 , wherein the base is one or two or more selected from the group consisting of KH 2 PO 4 , Na 2 HPO 4 .2H 2 O, Na 2 HPO 4 , Na 2 CO 3 , NaH 2 PO 4 , LiOAc, Li 2 CO 3 , NaOAc, K 2 HPO 4 , K 3 PO 4 , K 2 CO 3 , CsF, KHCO 3 , KOH, KF, KPF 6 , KOAc, NaF, CsOAc, CsOPiv, LiPF 6 , Li 3 PO 4 , LiF, and LiI. 11. The method of preparing a cyclic phosphinate compound of claim 5 , wherein a use amount of the base is 0.5 to 3.0 equivalents with respect to the phosphinic acid compound represented by Chemical Formula 6. 12. The method of preparing a cyclic phosphinate compound of claim 5 , wherein a ligand is further used. 13. The method of preparing a cyclic phosphinate compound of claim 12 , wherein the ligand is one or two or more selected from the group consisting of N-acetyl-L-leucine, Boc-Val-OH [N-(tent-butoxycarbonyl)-L-valine], N-Boc-L-isoleucine, Boc-L-leucine, Ac-Gly-OH [N-acetylglycine], N-Boc-L-isoleucine-hemihydrate, Ac-Ala-OH [N-acetyl-L-alanine], Ac-Phe-OH [N-acetyl-L-phenylalanine], pivalic acid, 2-methyl-2-phenylpropanoic acid, adamantane-1-carboxylic acid, (4-CF 3 —C 6 H 4 ) 3 P, (4-MeO—C 6 H 4 ) 3 P, (4-MeO—C 6 H 4 ) 3 P, (2,6-di-MeO—C 6 H 3 )3P, (2,4,6-tri-MeO—C6H2)3P, Xantphos [4,5-Bis(diphenylphosphino)-9,9-dimethylxanthene], XPhos [2-dicyclohexylphosphino-2′,4′,6′-triisopropylbiphenyl], CyJohnphos [(2-biphenyl)dicyclohexylphosphine], SPhos [2-dicyclohexylphosphino-2′,6′-dimethoxybiphenyl], Johnphos [(2-biphenyl)di-tert-butylphosphine], DPEphos [bis[(2-diphenylphosphino)phenyl]ether], DPPP [1,3-Bis(diphenylphosphino)propane], DPPE [1,2-Bis(diphenylphosphino)ethane], DPPF [1,1′-Bis(diphenylphosphino) ferrocene], tri-o-tolylphosphine, and tri-2-furylphosphine. 14. The method of preparing a cyclic phosphinate compound of claim 12 , wherein a use amount of the ligand is 0.1 to 1.0 equivalent with respect to the phosphinic acid compound represented by Chemical Formula 6.

Assignees

Inventors

Classifications

  • the ring phosphorus atom and one oxygen atom being part of a (thio)phosphinic acid ester: [IMAGE cpc-sch-C07F-1008.gif] (X = O, S) · CPC title

  • condensed with carbocyclic or heterocyclic rings or ring systems · CPC title

  • the ring phosphorus atom and, at least, one ring oxygen atom being part of a (thio)phosphonic acid derivative · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9487547B2 cover?
Provided are novel cyclic phosphinate derivatives and a method of preparing the same, and more particularly, cyclic phosphinate derivatives including benzoxaphosphole oxide derivatives and benzoxaphosphorin oxide derivatives, and a method of preparing the same. The cyclic phosphinate derivative according to the present invention may have pharmacological and physiological activities, be used as …
Who is the assignee on this patent?
Knu Industry Cooperation Found
What technology area does this patent fall under?
Primary CPC classification C07F9/657181. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Nov 08 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).